Ultimately, insulin pump users should be aware of the theoretical increase in insulin delivery and risk of hypoglycaemia during ascent and adjust their glucose monitoring and carbohydrate ingestion appropriately [7]. This evidence concerns the gene INS and Hypoglycemia.